(Total Views: 612)
Posted On: 11/23/2022 2:31:47 PM
Post# of 156338
The is no question in my mind that the Dec 7th Update is going to be good news. This is our experts covering NASH, Dr. Noureddin; HIV, Dr. Sacha; and the overview and strategy, Dr. Arman.
But what really struck me in the PR was Dr Stefan Glück who has been a Principal Investigator for over 37 breast cancer clinical studies. He has also served in roles for Regeneron and Celgene, focusing on immuno-oncology in solid tumors and acquiring early assets.
I repeat: Regeneron and Celgene, focusing on immuno-oncology in solid tumors and acquiring early assets. Acquiring early assets! Hello!
But what really struck me in the PR was Dr Stefan Glück who has been a Principal Investigator for over 37 breast cancer clinical studies. He has also served in roles for Regeneron and Celgene, focusing on immuno-oncology in solid tumors and acquiring early assets.
I repeat: Regeneron and Celgene, focusing on immuno-oncology in solid tumors and acquiring early assets. Acquiring early assets! Hello!
(9)
(0)
